Abstract
Over the past few years, great progress has been made in the development of high-affinity adenosine A(1) and/or A(2A) receptor antagonists-promising agents for the potential treatment of Parkinson's disease. Unfortunately, many of these compounds raise structure-related concerns. The present study investigated the effect of ring closures on the rA(1)/A(2A) affinity of compounds containing a highly reactive alpha,beta-unsaturated carbonyl system, hence providing insight into the potential of heterocycles to address these concerns. A total of 12 heterocyclic compounds were synthesised and evaluated in silico and in vitro. The test compounds performed well upon qualitative assessment of drug-likeness and were generally found to be free from potentially problematic fragments. Most also showed low/weak cytotoxicity. Results from radioligand binding experiments confirm that heterocycles (particularly 2-substituted 3-cyanopyridines) can replace the promiscuous alpha,beta-unsaturated ketone functional group without compromising A(1)/A(2A) affinity. Structure-activity relationships highlighted the importance of hydrogen bonds in binding to the receptors of interest. Compounds 3c (rA(1)K(i) = 16 nM; rA(2A)K(i) = 65 nM) and 8a (rA(1)K(i) = 102 nM; rA(2A)K(i) = 37 nM), which both act as A(1) antagonists, showed significant dual A(1)/A(2A) affinity and may, therefore, inspire further investigation into heterocycles as potentially safe and potent adenosine receptor antagonists.
Funding Information
  • North-West University

This publication has 100 references indexed in Scilit: